why choose us

First received: May 30, 2024

Clinical Trial: A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Joint Pain

Study Type: INTERVENTIONAL


Official Title: An Open-label, Phase 1b, Multi-site Trial to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Following a Single Dose of LEO 158968 in Subjects With Gout Flares

Brief Summary: The main objective of the study is to evaluate the effect on pain of a single, subcutaneous (SC) dose of LEO 158968 in participants with gout flares.

Read more